Mapmygenome Brings Down Cost of Genetic Testing Dramatically With Sugargene

Mapmygenome Brings Down Cost of Genetic Testing Dramatically With Sugargene

HYDERABAD, November 28, 2014 /PRNewswire/ --

Mapmygenome launched a new low cost personal genomics test, Sugargene, on November 28, 2014. Sugargene is a personal genomics test to understand the genetic risk of type 2 diabetes and obesity, nutrigenetics and management options. With this test, Mapmygenome aims to bring about lifestyle changes that can help people achieve optimum health and save on expensive treatments.

Anu Acharya, CEO of Mapmygenome, said, "Most of us have at least one person in the family suffering from diabetes and have seen how it painfully attacks the rest of the body. Diabetes is preventable but intervention must be done early. We listened to our customers and ensured that Sugargene is affordable for all and will provide both fun facts as well as a plan to work on towards a healthier life. We aim to combat two greatest global epidemics of our time - obesity and type 2 diabetes."

Sugargene costs INR 2,999. This test analyses DNA for genetic predisposition to type 2 diabetes and obesity; key traits related to nutrigenetics such as satiety levels, sugar cravings, and more; and prevention and treatment options.

About Mapmygenome

Mapmygenome is a molecular diagnostics company for people who are proactive about their health. Their products provide insights into the genetic basis of individuals' health, including traits, lifestyle, drug responses, inherited conditions, and diseases. By combining genetic report and health history with genetic counselling, Mapmygenome provides actionable steps for individuals and their physicians towards a healthier life.

Some of Mapmygenome's personal genomics products include - Genomepatri™, a comprehensive DNA-based health report covering over 100 conditions; Cardiomap™, DNA-based cardiac profile; Gynaecmap™, women's wellness predictor; Oncomap™, cancer profile; SMART™ SPORT, best sport and fitness indicator; and Brainmap™ for neuro, cognitive, psychiatric, and lifestyle wellness. Their latest service Sugargene™ tests for diabetes and obesity as well as nutrigenetics. For a complete listing of personal genomics products please see

In addition to personal genomics, Mapmygenome offers solutions in brain wellness and molecular diagnostics.

The molecular diagnostic portfolio include NGS panels on rare disorders, thalassemia, cystic fibrosis, muscular dystrophy, etc. For a complete listing please see

For more information, visit

Media Contact: Geethanjali Tanikella, [email protected], +91-9849723700, Manager - Corporate Communications, Mapmygenome

SOURCE Mapmygenome

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.